Peter Radovich
Net worth: 5 M $ as of 31/10/2026
Net worth: 5 M $ as of 31/10/2026
Peter Radovich is currently Independent Director at MBX Biosciences, Inc. since 2026 and President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. since 2024.
Former roles include Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc. from 2004 to 2006, Independent Director at Rain Oncology, Inc. from 2018 to 2024, Principal at Chiron Corp.
from 2004 to 2006, Vice President-Global Product Kyprolis at Onyx Pharmaceuticals, Inc. from 2013 to 2014, and Senior Vice President-Operations at Global Blood Therapeutics, Inc. from 2016 to 2020.
Education includes an MBA from the University of Washington and an undergraduate degree from Texas Christian University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/06/2026 | 57,260 ( 0.09% ) | 5 M $ | 31/10/2026 |
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | President | 16/01/2024 |
| MBX BIOSCIENCES, INC. | Director/Board Member | 20/10/2026 |
| Companies | Position | End |
|---|---|---|
| RAIN ONCOLOGY INC. | Director/Board Member | 25/01/2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/01/2014 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Director/Board Member | 01/09/2006 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01/01/2006 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions